PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity

PTEN 抗癌基因对神经元功能的影响

• 批准号: 7391290
• 负责人: MICHAEL G KAPLITT
• 金额: $ 14.58万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-08-15 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7391290
• 关键词: 1-Methyl-4-phenylpyridinium; 1-Phosphatidylinositol 3-Kinase; Adult; Age; Aging; Alzheimer' s Disease; Alzheimer' s disease model; Amyloid beta-Protein; Amyloid beta-Protein Precursor; Animals; Apoptosis; Award; Biological; Brain; Caspase; Cell Line; Cell Nucleus; Cell physiology; Cells; Clinical; Cultured Cells; Cytoplasm; DNA Microarray Chip; DNA Microarray format; Data; Development; Education; Environment; GTP Cyclohydrolase; Gene Expression; Genes; Goals; Growth; Hyperplasia; Institution; Life; Lipids; Localized; Malignant neoplasm of brain; Measures; Mentors; Messenger RNA; Mitogen-Activated Protein Kinases; Modeling; Mutate; NGFR Protein; Nerve Degeneration; Nerve Growth Factors; Neurodegenerative Disorders; Neuronal Differentiation; Neurons; Neurotoxins; Oxidopamine; PC12 Cells; PTEN gene; PTEN protein; Parkinson Disease; Pathway interactions; Pharmaceutical Preparations; Pheochromocytoma; Phosphoinositide-3-Kinase, Catalytic, Gamma Polypeptide; Phosphoric Monoester Hydrolases; Phosphorylation; Predisposition; Process; Protein Overexpression; Protein phosphatase; Proteins; Proto-Oncogene Proteins c-akt; Rattus; Reporting; Role; Scientist; Series; Signal Transduction; Small Interfering RNA; TP53 gene; Tissues; Toxic effect; Toxin; Transgenic Mice; Tumor Suppressor Genes; Tyrosine 3-Monooxygenase; age effect; age related; aged; cancer cell; cholinergic neuron; distraction; inhibitor/antagonist; malignant phenotype; member; mutant; neuron loss; neuronal survival; neurotoxic; neurotoxicity; neurotrophic factor; response; tissue culture; transcriptional coactivator p75

DESCRIPTION (provided by applicant): The PTEN anti-oncogene is among the most frequently mutated genes in malignant brain tumors. Normally, PTEN is a lipid phosphatase which blocks malignant phenotypes primarily by inhibiting the PI3 Kinase/AKT pathways, but PTEN can also act as a protein phosphatase. PTEN is expressed in brain late in development, and neuronal expression continues throughout adult life. Although loss of PTEN can cause neuronal hyperplasia, little is known about the role of PTEN in neuronal development or in normal neurons. Pathways influenced by PTEN suggest that this anti-oncogene may increase neuronal sensitivity to toxicity and/or degenerative processes, which is supported by our preliminary data. This proposal will first determine whether PTEN can modulate sensitivity of cultured neuron-like cells to toxins used in models of Alzheimer's disease and Parkinson's disease. While studying this hypothesis, we have unexpectedly found that PTEN blocks NGF signaling in PC12 cells, and this appears to be at least partially due to inhibition of expression of trkA and p75 NGF receptors at the protein and mRNA levels. DNA microarray then revealed that PTEN can inhibit expression of several genes, including tyrosine hydroxylase and GTP cyclohydrolase 1. Since this may also have implications for neuronal function and for Parkinson's disease, the second Aim of this proposal will also explore the mechanism by which PTEN inhibits expression of these genes. The final Aim of this proposal will explore the effect of age and neurotoxins used in models of neurodegenerative disorders on PTEN levels and function to determine the biological relevance of data generated from the first two Aims. These studies and my development as an independent clinical scientist will be significantly advanced by Dr. M. Flint Beal, who will serve as my sponsor and who is a leading expert in neuronal degeneration in PD and AD. Additional mentoring by Dr. Eric Holland, a leading expert on anti-oncogene signal transduction, will also add significantly to my scientific growth and will also help me to realize many of the Specific Aims of this proposal. The environment at Cornell and the strong support of my institution will permit me to focus upon these studies with minimal distractions. My scientific background is substantial, and this will facilitate realization of the goal of this project. This plan outlined in this award will, however, enhance previously underserved aspects of my education while focusing on an important scientific question, in order to promote a successful transition to scientific independence.

描述（由申请人提供）：PTEN抑癌基因是恶性脑肿瘤中最常见的突变基因之一。通常，PTEN是一种脂质磷酸酶，其主要通过抑制PI 3激酶/AKT途径来阻断恶性表型，但PTEN也可以充当蛋白磷酸酶。PTEN在发育后期在脑中表达，并且神经元表达在整个成年生活中持续。尽管PTEN的缺失可导致神经元增生，但关于PTEN在神经元发育或正常神经元中的作用知之甚少。受PTEN影响的途径表明，这种抑癌基因可能会增加神经元对毒性和/或退行性过程的敏感性，这得到了我们的初步数据的支持。这项提议将首先确定PTEN是否可以调节培养的神经元样细胞对阿尔茨海默病和帕金森病模型中使用的毒素的敏感性。在研究这一假设时，我们意外地发现PTEN阻断了PC 12细胞中的NGF信号传导，这似乎至少部分是由于在蛋白质和mRNA水平上抑制了trkA和p75 NGF受体的表达。DNA微阵列显示，PTEN可以抑制几个基因的表达，包括酪氨酸羟化酶和GTP环水解酶 1.由于这也可能对神经元功能和帕金森病有影响，因此本提案的第二个目的也将探索PTEN抑制这些基因表达的机制。本提案的最终目的将探索神经退行性疾病模型中使用的年龄和神经毒素对PTEN水平和功能的影响，以确定前两个目的产生的数据的生物学相关性。这些研究和我作为一个独立的临床科学家的发展将大大推进博士。弗林特比尔，他将作为我的赞助人，他是帕金森病和阿尔茨海默病神经元变性的主要专家。Eric Holland博士是抗癌基因信号转导方面的领先专家，他的额外指导也将大大促进我的科学发展，并帮助我实现本提案的许多具体目标。康奈尔大学的环境和我所在机构的大力支持将使我能够专注于这些研究，并尽可能减少干扰。我的科学背景是坚实的，这将有助于实现这个项目的目标。然而，在这个奖项中概述的这个计划将加强我以前教育的不足方面，同时专注于一个重要的科学问题，以促进向科学独立的成功过渡。